Lu Li

机构：Shandong Tumor Hospital, Shandong First Medical University · ORCID：0000-0003-1643-1684

发表论文 187 篇 · 总被引 3213 次 · h-index 25

代表论文

• Efficacy and safety of olezarsen in lowering apolipoprotein C-III and triglycerides in healthy Japanese Americans (2024 · Lipids in Health and Disease · 被引 15)
• Differential effects of volanesorsen on apoC-III, triglycerides, and pancreatitis in familial chylomicronemia syndrome diagnosed by genetic or nongenetic criteria (2024 · Journal of clinical lipidology · 被引 12)
• Association between Life’s Essential 8 and cataract among US adults (2024 · Scientific Reports · 被引 9)
• A novel method for screening malignant hematological diseases by constructing an optimal machine learning model based on blood cell parameters (2025 · BMC Medical Informatics and Decision Making · 被引 8)
• Brief communication: Strong concordance of the North American Familial Chylomicronemia Syndrome Score with a positive genetic diagnosis in patients from the Balance study (2025 · Journal of clinical lipidology · 被引 5)
• Key indicators for guiding tocilizumab therapy to prevent orbital decompression surgery in hormone-resistant dysthyroid optic neuropathy (2025 · Frontiers in Immunology · 被引 4)